Chronic Disease Management Market Research Report: By Solution (Educational Solution, Implementation Solution, Consulting Solution and others), Delivery Mode (Cloud-Based, On-Premises and Web-Based), Application (Arthritis, Cardiovascular Disease, Cancer, Diabetes and others), End-User (Providers, Payers) and Region (Americas, Europe, Asia-Pacific, Middle East & Africa) - Forecast till 2027

Chronic Disease Management Market Overview

According to the latest research reports, the chronic disease management market size is predicted to reach USD 4000 Million in the year 2018 and it is predicted to register a CAGR of 14.5% during the forecast period. Chronic disease management consists of a predefined set of actions focused primarily on delivering high-quality healthcare and improving patients' quality of life. Chronic illness management Solutions include a wide range of solutions, such as recommendations for chronic diseases self-management model of chronic illness conditions, multidisciplinary treatment, and lifestyle counseling to raise knowledge about various diseases.

One of the primary factors anticipated to fuel the rise and demand for chronic disease treatment is the global increase in the prevalence of chronic diseases such as COPD, asthma, cancer, diabetes, stroke, or musculoskeletal problems. Furthermore, from 2021 to 2028, the chronic kidney disease management market is anticipated to grow due to a growth in the number of people with chronic diseases and a rise in awareness of nutritional management of chronic kidney disease. Similarly, rising degrees of digitalization integration in healthcare systems and facilities and an increase in the geriatric population are expected to drive chronic diseases management market expansion. Furthermore, better service provider offerings have increased demand for chronic disease management services, which are likely to be key contributors to the chronic disease management market growth. The fast increase in the medical tourism sector, as well as the fast rise in healthcare IT solutions, which have driven the development of chronic disease management services, are projected to provide substantial growth possibilities for the chronic disease management market from 2021 to 2028.

This report contains all the information on the chronic diseases management market trends, research, and market strengths. The report also contains the culmination of dynamics, segmentation, key players, regional analysis, and other important factors. And a detailed analysis of the chronic diseases management market statistics and forecast to 2026 is also included in the report.

Covid 19 Analysis

The vast majority of funds and resources have been dedicated to the containment of the new coronavirus epidemic, which remains uncontrollable despite the global lockdown. This issue is delaying therapy for those suffering from chronic illnesses. The COVID-19 epidemic, on the other hand, has increased the usage of different digital platforms that assist individuals to obtain better access to medical treatment, which can be beneficial to the care management industry and increase demand for chronic illness management solutions.

Market Dynamic

Drivers

Growing awareness of the importance of life-threatening diseases, as well as rising healthcare spending, are the major drivers driving the growth of the worldwide chronic diseases market size. According to the World Health Organization (WHO), chronic illnesses would account for nearly three-quarters of all fatalities globally by 2020, with ischemic heart disease accounting for 71% of fatalities and diabetes accounting for 70%.

The integration of digital technology into healthcare systems in developed nations increased awareness about the significance of chronic and life-threatening illnesses, and rising healthcare expenditures are projected to drive the worldwide chronic illness management market during the projected period.

Opportunities

In the future, the chronic disease management market is expected to be fueled by the use of digital technologies and rising IT healthcare services.

Restraints

Non-compliance and a lack of adherence among patients are expected to restrict the growth of the chronic disease management market, while a shortage of technically trained experts and workforce necessary for the treatment of these illnesses may provide a barrier to the industry's expansion.

Challenges

Non-compliance and a lack of adherence among patients are expected to restrict the chronic disease management market's growth, while a shortage of technically trained experts and labor necessary for the treatment of these illnesses might provide a challenge to the market's expansion.

Cumulative Growth Analysis

According to the Centers for Disease Control and Prevention, chronic illnesses affect 6 out of 10 individuals in the United States. Furthermore, according to the National Association of Chronic Illness Directors, chronic disease consumes over 75% of all healthcare expenditures in the United States each year. In terms of public insurance, chronic illness treatment accounts for an even greater amount of expenditures, accounting for 96 cents on the dollar for Medicare and 83 cents on the dollar for Medicaid. The chronic care management market is growing as a result of a large amount of money spent on chronic diseases in healthcare.

According to the National Center for Biotechnology Information, chronic illnesses such as cancer, cardiovascular disease, chronic respiratory disease, diabetes, and mental illness account for 855 fatalities in the European Union. Furthermore, cancer-related healthcare costs in European Union member states accounted for 6% of overall healthcare spending in 2015.

Value Chain Analysis

According to the reports, the chronic disease management market has been segmented into solution, delivery mode, application, end-user, and region.  The market has been divided into solutions such as instructional solutions, implementation solutions, consulting solutions, and others. The chronic disease management market has been categorized based on application into safety arthritis, cardiovascular disease, cancer, diabetes, and others. The chronic disease management market has been divided into three segments depending on delivery mode: cloud-based, on-premises, and web-based. The chronic disease management market has been divided into three segments based on end-user: providers, payers, and others.

The chronic disease management market has been divided into four regions: the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Chronic Disease Management market in the Americas has been further subdivided into North America and Latin America, with North America split into the United States and Canada. The European Chronic Disease Management market is divided into two sections: Western Europe and Eastern Europe. Western Europe is further subdivided into Germany, France, the United Kingdom, Italy, Spain, and the rest of Western Europe. The Asia-Pacific chronic illness management market has been divided into Japan, China, India, Latin Korea, Australia, and the rest of Asia-Pacific.

Chronic Disease Management Market Share (%), by Region, 2018  

Source: Centers for Disease Control and Prevention (CDC), Eurostat, White Papers, Company Presentations, and Annual Reports

Segmentation Overview

The chronic disease management market is segmented based on the solution, delivery mode, application, end-user, and region. The global chronic disease management market is expected to witness decent growth during the forecast period.

By Application

The chronic disease management market is segmented into safety arthritis, cardiovascular disease, cancer, diabetes, and others based on the application.

By end-users

Based on the propulsion types, the chronic disease management market is segmented into providers, payers, and others.

Regional Analysis

According to the reports, based on region, the chronic disease management market has been segmented into the Americas, Europe, Asia-pacific, and the middle east & Africa. Because of the rising incidence of chronic diseases, increased R&D investment for pharma and biotech firms, and increased healthcare spending, the Americas are expected to lead the worldwide chronic disease management market. Due to rising healthcare costs and an aging population, Europe accounted for the second-largest chronic disease management market. Furthermore, growing healthcare spending is propelling market expansion. The Asia-Pacific region was expected to be the fastest expanding area for the chronic kidney diseases management market companies. The market is projected to expand as a result of expanding population and desire for technologically improved therapies. Cancer is prevalent in emerging nations and cities such as Japan, Hong Kong, and India, which promote market expansion.

The Middle East and Africa markets have a small proportion of the worldwide chronic illness management market due to a lack of healthcare facilities, a low per capita income, and individuals in developing nations who are unaware of new treatment approaches. However, the chronic disease management market is projected to expand because of increased hospitalization and rising product demand in the Middle East.

Competitive landscape

Due to the large number of competitors participating in the chronic disease management companies, the market shares are extremely effervescent. To expand their product offering and attract more consumers, hospitals are focused on delivering tailored solutions.

Major Key Players

• TriZetto Corporation (US)


• Infosys Limited (India)


• Pegasystems Inc. (US)


• Siemens Healthcare Private Limited (Germany)


• MINES & Associates, Inc. (US)


• Allscripts Healthcare Solutions, Inc. (US)


• Koninklijke Philips NV (Netherlands)


• EXL Healthcare (New York)


• Harmony Information Systems, Inc.(US)


• ScienceSoft USA Corporation (US)

Report Overview

The following report comprises of –

• Market overview 


• Covid 19 Analysis


• Market Dynamic


• Drivers


• Opportunities


• Restraints


• Challenges


• Cumulative Growth Analysis


• Value Chain Analysis


• Segmentation Overview


• By Application


• By End-Users


• Regional Analysis


• Competitive landscape

 Recent Developments

• University Hospitals Geauga opened a new chronic illness treatment center in April 2019. Such initiatives are largely focused on the senior population, who may have difficulty remembering certain parts of the lifestyle to be followed.

Chronic Disease Management Market, by Solution

• Educational Solution


• Implementation Solution


• Consulting Solution


• Others

Chronic Disease Management Market, by Delivery Mode  

• Cloud-Based


• On-Premises


• Web-Based

Chronic Disease Management Market, by Application

• Arthritis


• Cardiovascular Disease


• Cancer


• Diabetes


• Others

Chronic Disease Management Market, by End-User

• Providers


• Payers


• Others

Chronic Disease Management Market, by Region

• North America




• US


• Canada




• Europe




• Germany


• France


• UK


• Italy


• Spain


• Rest of Europe




• Asia-Pacific




• China




• Japan


• India


• Australia


• South Korea


• Rest of Asia-Pacific






• Rest of the World




• Middle East


• Africa


• Latin America

Report Scope:

Report Attribute/Metric	Details
Market Size	2018: USD 4000 Million 2027: Significant Value
CAGR	14.5% (2019-2025)
Base Year	2019
Forecast Period	2020-2027
Historical Data	2018
Forecast Units	Value (USD Million)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered	Solution, Delivery Mode, Application, End-User
Geographies Covered	North America, Europe, Asia-Pacific, and Rest of the World (RoW)
Key Vendors	TriZetto Corporation (US), Infosys Limited (India), Pegasystems Inc. (US), Siemens Healthcare Private Limited (Germany), MINES & Associates, Inc. (US), Allscripts Healthcare Solutions, Inc. (US), Koninklijke Philips NV (Netherlands), EXL Healthcare (New York), Harmony Information Systems, Inc.(US), ScienceSoft USA Corporation (US)
Key Market Opportunities	New product launches and R&D Amongst major key Players
Key Market Drivers	Rising awareness about the seriousness of life-threatening diseases Rising healthcare expenditure

Speak to Analyst Ask for Customization

Frequently Asked Questions (FAQ) :

---